🇰🇷 Datroway in South Korea

Datroway (DERUXTECAN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Marketing authorisation holder: DAIICHI SANKYO
  • Status: likely_approved

Datroway in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Datroway approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Datroway in South Korea?

DAIICHI SANKYO holds the South Korean marketing authorisation.